Breast cancer treatment
131 – 140 of 259
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy
- Contribution to journal › Article
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
- Contribution to journal › Article
-
Mark
Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- Contribution to journal › Article
-
Mark
Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
- Contribution to journal › Article
-
Mark
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
- Contribution to journal › Article
-
Mark
Prognostic Factors and Metastatic Routes in Lobular Breast Cancer. Same Same but Different.
(2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
The distribution of circulating tumor cells is different in metastatic lobular compared to ductal carcinoma of the breast –long term prognostic significant
- Contribution to journal › Article
-
Mark
Mammographic tumour appearance is related to clinicopathological factors and surrogate molecular breast cancer subtype
- Contribution to journal › Article
-
Mark
Statin use, HMGCR expression, and breast cancer survival – The Malmö Diet and Cancer Study
- Contribution to journal › Article
